PBS pricing (diabetes)
Ozempic is PBS-subsidised for type 2 diabetes at approximately $41.30/script ($7.70 concession). This is only available for the diabetes indication — not for weight loss.
Ways to save
- Compare providers above — prices vary by $5/month for the same medication
- If your provider issues e-scripts, fill at a discount pharmacy (Chemist Warehouse)
- Discuss dose optimisation with your doctor — lower doses cost less
PBS pricing for diabetes
If you have type 2 diabetes, Ozempic is PBS-subsidised at approximately $41.30 per script ($7.70 with a concession card). This makes it by far the cheapest GLP-1 option available — roughly 10x cheaper than Wegovy or Mounjaro on private prescription. Your doctor or endocrinologist prescribes it for diabetes management, and the weight loss is a beneficial side effect.
Private pricing (non-PBS)
If you don't qualify for PBS (e.g., you don't have diabetes), Ozempic costs $130–190/month on private prescription. However, since October 2024, new off-label prescriptions for weight loss are restricted — you generally cannot get Ozempic prescribed for weight loss anymore.
Your cheaper alternatives for weight loss
If you're looking at Ozempic for weight loss and can't access it: Wegovy ($400–460/mo) is the same ingredient at a higher dose, approved for weight loss. If Wegovy gets PBS listed, eligible patients would pay ~$31.60/script. Duromine (~$100/mo) offers a budget-friendly short-term alternative.